Patent · US Active

Pharmaceutical formulations

US11266649B2 · kind B2 · utility

1Cited by

1References

16Claims

0Family size

Assignee

Corvus Pharmaceuticals, Inc. · US

Inventors

Jingrong Xu · Burlingame, US
William Jones · Oakland, US
Felicia Flicker · Burlingame, US
Bret Berner

Key dates

Filing date	Feb 1, 2019
Grant date	Mar 8, 2022
Priority date	—
Expiry date	May 20, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides, inter alia, pharmaceutical compositions comprising micronized drug particles of adenosine A2A receptor antagonists, and methods of treating cancer using the pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.